GLP-1 price cuts announced for Wegovy, Ozempic
💰 **Prices Coming Down!** Here's some really encouraging news: Novo Nordisk just announced they're cutting the list prices for Wegovy and Ozompic to $675 per month starting in 2027. While insurance coverage still matters, this is a meaningful step toward making your GLP-1 journey more affordable and accessible. We've been cheering for solutions that help more of our community members access these life-changing medications, and price reductions are a big part of that picture!
Novo Nordisk is cutting list prices for Wegovy, Ozempic and Rybelsus to $675 a month starting in 2027, aiming to improve affordability for insured patients.
Related Articles
What Is Food Noise? The Science Behind GLP-1s and Quiet Minds
Food noise is the constant, intrusive mental chatter about food that millions experience daily. This deep dive explains the neuroscience of how GLP-1 medications like semaglutide and tirzepatide quiet food noise by modulating the hypothalamus and reward pathways, distinguishes food noise from physiological hunger, and provides three evidence-based strategies — trigger-food visibility friction, small-plate pacing, and anchor meal templates — for managing it. Backed by research from JAMA, Cleveland Clinic, and NHS guidance.
Read more →
Why 53.6% of GLP-1 Users Quit Within a Year (And How to Be in the Other Half)
A JAMA Network Open study of 125,474 adults found that 53.6% discontinue GLP-1 medications within one year. This evidence-based analysis examines the six key reasons — side effects, cost, supply shortages, unrealistic expectations, premature cessation, and lack of support structure — and provides clinically-grounded strategies for staying on track, including the Weekly Plateau Scoreboard, Rebound Early-Warning Threshold, and structured side effect management. Anchored by STEP 4 trial data showing 14.8 percentage points difference between continuing and stopping.
Read more →Oral GLP-1 Pills 2026: Wegovy, Foundayo, and Orforglipron Compared
Three oral GLP-1s now have FDA approval: Wegovy pill ($675/mo, Dec 2025), Foundayo orforglipron ($149/mo, April 2026), and Rybelsus (off-label). Trial data shows oral matches injection efficacy within 1-3pp. Here is the full comparison: efficacy, dose timing, side effects, cost.
Read more →Ready to start your GLP-1 journey?
Gila helps you build lasting habits, understand your body, and stay on track. Join the pilot for free.
Join the Pilot